The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needs.
AIMS: Despite their established benefits, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) remain underutilized for type 2 diabetes mellitus (T2DM) management, which indicates that subcutaneous injection is an unfavorable mode of delivery from the pa..... Read More